Warren S. Pear

University of Pennsylvania — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

84h-index24.6kcitations277works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Developmental Biology and Gene Regulation(67), Cancer-related gene regulation(46), Epigenetics and DNA Methylation(40), Immune Cell Function and Interaction(33), T-cell and B-cell Immunology(32)

Publications277 total

3137 – CELL FREE TARGETED THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Experimental Hematology·2024
The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR+ CD8+ effector state, and its deletion improves checkpoint blockade
Cell Reports·2023· 11 citedOpen Access
TIPE proteins control directional migration of human T cells via GPCR and lipid second messenger signaling
The Journal of Immunology·2023Open Access
Supplementary Figures S1 - S7 from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Data from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Methods from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Table S9 from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Tables S1 - S8 from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Figures S1 - S7 from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Data from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Methods from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Table S9 from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Table S10 from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Tables S1 - S8 from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Table S10 from Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma
2023Open Access
Supplementary Figure 2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Figure Legends 1-2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Figure 1 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Figure Legends 1-2 from Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes
2023Open Access
Supplementary Materials 1 from Srcasm Inhibits Fyn-Induced Cutaneous Carcinogenesis with Modulation of Notch1 and p53
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Jon C. Aster(24), Lanwei Xu(16), Stephen C. Blacklow(12), Ivan Maillard(9), Yumi Yashiro–Ohtani(7), Olga Shestova(7), David Allman(6), Fredrick G. Karnell(6), John C. Pui(5), Andrew P. Weng(5), Avinash Bhandoola(5), Yiping He(5), Sonia Bakkour(4), Carlos G. Rodríguez(4), Hong Sai(4), Terry Fang(4), Lili Tu(4), Karen Keeshan(4), Martin Scott(3), David Baltimore(3)